{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-036630","form_type":"8-K","ticker":"AYTU","cik":"0001385818","company_name":"AYTU BIOPHARMA, INC","filed_at":"2024-12-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.311065+00:00","generated_at":"2026-05-29T08:29:52.516874+00:00","sec_items":["7.01","9.01"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Aytu settles derivative shareholder suit; court hearing Jan 13, 2025","bullets":["Settlement approval hearing scheduled for January 13, 2025 in Delaware Chancery Court.","Aytu to pay $250,000 in attorneys' fees and $5,000 service award to plaintiff.","Governance enhancements include new independent board member, CEO/Chair separation, enhanced insider trading oversight.","D&O defendants released; claims against Armistice defendants preserved with Aytu remaining neutral."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-036630","json":"https://secwatch.observer/filing/0001437749-24-036630.json","markdown":"https://secwatch.observer/filing/0001437749-24-036630.md","text":"https://secwatch.observer/filing/0001437749-24-036630.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1385818/000143774924036630/0001437749-24-036630-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1385818/000143774924036630/aytu20241203_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T08:29:52.516874+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}